Mr. Brett Allan Beuning, D.P.T. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1324 Common St, Ste 307, New Braunfels, TX 78130 Phone: 830-625-7310 Fax: 830-625-3228 |
Jennifer C Heisey, PT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1551 N Walnut Ave Ste 47, New Braunfels, TX 78130 Phone: 830-358-1151 Fax: 830-626-3422 |
Dr. Xin Zhang, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 43 Yu Dr, New Braunfels, TX 78130 Phone: 830-608-9300 Fax: 830-626-1727 |
Nathan J.p. Herrera-keselring, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 529 Zapata Cir, New Braunfels, TX 78130 Phone: 361-877-8508 |
Norman M Whisenant, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 614 C South Business Ih 35 #44, New Braunfels, TX 78130 Phone: 210-710-4265 Fax: 830-620-5405 |
Maria R Lomba, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2041 Sundance Pkwy, New Braunfels, TX 78130 Phone: 210-387-5304 |
Dr. William Ray Culver, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 881 Rock St, New Braunfels, TX 78130 Phone: 830-620-7422 Fax: 830-625-7240 |
Dr. Justin Frederick Black, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 301 Main Plz # 170, New Braunfels, TX 78130 Phone: 830-625-6700 |
News Archive
Millennium: The Takeda Oncology Company today announced the presentation of results from an ongoing Phase II study of MLN8237, an investigational Aurora A kinase inhibitor, in patients with relapsed/refractory aggressive B-cell and T-cell non-Hodgkin lymphoma.
The finding sheds new light on decades of debate about how the human brain's language centers may actually be enhanced when faced with two or more languages as opposed to only one.
Frost & Sullivan has announced 44 world-class companies as winners of the 2015 CIO Impact Awards. The recipients are comprised of enterprise teams, individuals, and technology partners enabling breakthrough new business models and strategies through the innovative use of transformative technologies.
Early findings from a Medtronic, Inc. sponsored study show heart failure patients with moderate ejection fractions, over 35 percent, may receive comparable benefits from cardiac resynchronization therapy (CRT) as compared to those with low ejection fractions of equal to or less than 35 percent.
› Verified 4 days ago